Assignee profile:

Sanofi Pasteur

City:

Lyons

Country:

France

Published Applications:

31

Last publication date:

2024-09-12

Patent Grants:

31

Last grant date:

2025-04-01

Top Inventors for applications by Sanofi Pasteur

These are the the leading inventors for applications assigned to Sanofi Pasteur:

Recent patent applications by Sanofi Pasteur

Sanofi Pasteur based in Lyons, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-09-12 ✅ Patent 12,263,213 granted on 2025-04-01
US20240299524A1
Human necessities

Compositions for use in treatment of

#2 | 2024-04-25 ✅ Patent 12,569,549 granted on 2026-03-10
US20240131142A1
Human necessities

FLAVIVIRUS VACCINE

#3 | 2024-01-25 ✅ Patent 12,496,335 granted on 2025-12-16
US20240024453A1
Human necessities

ZIKA VIRUS VACCINE

#4 | 2023-11-09 ✅ Patent 12,515,845 granted on 2026-01-06
US20230356878A1
Performing operations; transporting

Internal cardboard support for receiving pharmaceutical products, packaging and method for packaging

#5 | 2022-02-17 ✅ Patent 11,452,772 granted on 2022-09-27
US20220047692A1
Human necessities

Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same

#6 | 2021-07-08 ✅ Patent 11,723,967 granted on 2023-08-15
US20210205434A1
Human necessities

Zika virus vaccine

#7 | 2021-06-24 ✅ Patent 12,343,306 granted on 2025-07-01
US20210186809A1
Human necessities

Ready-to-sell packaging unit containing at least one pharmaceutical product, set including a plurality of such packaging units and method for producing such packaging unit

#8 | 2021-05-27 ✅ Patent 11,471,521 granted on 2022-10-18
US20210154289A1
Human necessities

Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same

#9 | 2021-03-11 ✅ Patent 11,931,406 granted on 2024-03-19
US20210069315A1
Human necessities

Flavivirus vaccine

#10 | 2021-01-28 ✅ Patent 11,207,403 granted on 2021-12-28
US20210023202A1
Human necessities

Human cytomegalovirus immunogenic composition

#11 | 2020-09-17 ✅ Patent 11,690,903 granted on 2023-07-04
US20200289637A1
Human necessities

Compositions for booster vaccination against dengue

#12 | 2020-09-03 ✅ Patent 11,524,069 granted on 2022-12-13
US20200276301A1
Human necessities

Human cytomegalovirus immunogenic composition

#13 | 2019-01-17 ✅ Patent 10,577,398 granted on 2020-03-03
US20190016760A1
Chemistry; metallurgy

Multimerization of recombinant protein by fusion to a sequence from lamprey

#14 | 2018-10-04 ✅ Patent 10,772,946 granted on 2020-09-15
US20180280491A1
Human necessities

Immunogenic compositions against

#15 | 2018-07-12 ✅ Patent 10,857,222 granted on 2020-12-08
US20180193447A1
Human necessities

Concomitant dengue and yellow fever vaccination

#16 | 2018-05-10 ✅ Patent 10,232,029 granted on 2019-03-19
US20180125959A1
Human necessities

Compositions comprising proteins

#17 | 2018-03-01 ✅ Patent 10,118,951 granted on 2018-11-06
US20180057539A1
Chemistry; metallurgy

Multimerization of recombinant protein by fusion to a sequence from lamprey

#18 | 2017-10-26 ✅ Patent 10,946,087 granted on 2021-03-16
US20170304426A1
Human necessities

Vaccine compositions against dengue virus diseases

#19 | 2017-07-27 ✅ Patent 10,144,940 granted on 2018-12-04
US20170211111A1
Chemistry; metallurgy

Method for producing type B antigens

#20 | 2015-09-17 ✅ Patent 9,938,055 granted on 2018-04-10
US20150259111A1
Performing operations; transporting

Method of storing a vaccine containing an aluminum adjuvant

#21 | 2015-07-09 ✅ Patent 9,982,240 granted on 2018-05-29
US20150191703A1
Chemistry; metallurgy

Production of infectious influenza viruses

#22 | 2015-06-18 ✅ Patent 9,556,464 granted on 2017-01-31
US20150167036A1
Chemistry; metallurgy

Method for producing type B antigens

#23 | 2014-08-21 ✅ Patent 9,770,505 granted on 2017-09-26
US20140234422A1
Human necessities

Vaccine composition with aluminium hydroxide nanoparticles

#24 | 2012-04-05 ✅ Patent 8,795,688 granted on 2014-08-05
US20120083585A1
Chemistry; metallurgy

Dengue serotype 2 attenuated strain

#25 | 2012-04-05 ✅ Patent 9,169,298 granted on 2015-10-27
US20120083584A1
Chemistry; metallurgy

Dengue serotype 1 attenuated strain

#26 | 2012-02-23 ✅ Patent 9,019,496 granted on 2015-04-28
US20120044494A1
Physics

Method for estimating the amount of entities deposited on microparticles in suspension in a solution, associated device and use of said device

#27 | 2010-07-08 ✅ Patent 8,067,566 granted on 2011-11-29
US20100174057A1
Chemistry; metallurgy

Dengue serotype 2 attenuated strain

#28 | 2010-06-03 ✅ Patent 8,067,565 granted on 2011-11-29
US20100137571A1
Chemistry; metallurgy

Dengue serotype 1 attenuated strain

#29 | 2010-01-21 ✅ Patent 8,142,795 granted on 2012-03-27
US20100015180A1
Chemistry; metallurgy

Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses

#30 | 2007-02-01 ✅ Patent 7,641,908 granted on 2010-01-05
US20070026016A1
Chemistry; metallurgy

Dengue serotype 2 attenuated strain

#31 | 2006-12-28 ✅ Patent 7,641,907 granted on 2010-01-05
US20060292172A1
Chemistry; metallurgy

Dengue serotype 1 attenuated strain

Also check out Sanofi Pasteur's (Lyons, France) applicant profile with 24 patent applications submitted.

AssigneeID:

386875 ⎘